Racial Differences in Survival and Response to Therapy in Patients with Metastatic Colorectal Cancer: A Secondary Analysis of CALGB/SWOG 80405 (Alliance A151931)
- Citation:
- Cancer vol 127 (20) 3801-3808
- Year:
- 2021
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- Alliance-data-source,-internal-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 11
- Parents:
- None
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Disparities
- Sec. Committees:
- GI
- Pharmas:
- Bristol-Myers Squibb, Genentech, Myriad, Pfizer, and Sanofi
- Grants:
- UG1 CA189823, U10 CA180821, U10 CA180882, UG1CA232760, UG1CA233327, UG1 CA233329, UG1 CA233331, UG1 CA233373, U10 CA180888, UG1 CA180830 (SWOG)
- Corr. Author:
- Authors:
- Rebecca A. Snyder Jun He Jennifer Le-Rademacher Fang-Shu Ou Andrew B. Dodge Tyler J. Zemla Electra D. Paskett George J. Chang Federico Innocenti Charles Blanke Heinz-Josef Lenz Blase N. Polite Alan P. Venook
- Networks:
- CA011, CA824, LAPS-IL057, LAPS-MN026, LAPS-NC007, LAPS-OH007, LAPS-TX035, OR013
- Study
- Alliance-A151931
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-80405
- Phases:
- N/A, 3
- Keywords: